Skip to main content

Table 2 Clinical characteristics of CAD patients

From: The GPIIIA PlA2 polymorphism is associated with an increased risk of cardiovascular adverse events

Variable PlA1 (n = 300) PlA2 (n = 100) p Value
Age 60 ± 10 62.1 ± 8.6 0.72
Male sex (%) 90 81 0.03
Hypertension (%) 56 57 0.82
Diabetes (%) 29.3 19.4 0.11
Smoking (%) 58.6 53.8 0.45
Dyslipidemia (%) 55.2 53.8 0.81
Obesity (%) 9.5 7.7 0.89
Family history of CAD (%) 38.2 33.4 0.37
Previous AMI (%) 10.9 15.4 0.35
Previous PCI (%) 10.9 15.4 0.35
Previous CABG (%) 9.1 3.8 0.15
LVEF prior to PCI, mean ± SD 47 ± 10 51 ± 8 0.06
  1. PCI: Percutaneous coronary intervention
  2. LVEF: Left ventricular ejection fraction